News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Meth-Related HF: Challenges at the Intersection of CVD and Addiction Caitlin E. Cox December 06, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest Todd Neale November 29, 2022
News Daily News Novel Machine-Learning Score Can Predict FFR-Defined Ischemia Better Than Visual Stenosis Yael L. Maxwell October 25, 2022
News Daily News Older Adults See Rebound in Rates of HF-Related Death: CDC Data Caitlin E. Cox September 09, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News ‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19 L.A. McKeown August 10, 2022
News Conference News EAS 2022 Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively Michael O'Riordan May 27, 2022
News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Daily News CVD Hospitalizations Spiked in Aftermath of 2020 US Election Michael O'Riordan April 22, 2022
Video » Interview ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib April 3, 2022